Cargando…
Engineering γδ T Cells: Recognizing and Activating on Their Own Way
Adoptive cell therapy (ACT) with engineered T cells has emerged as a promising strategy for the treatment of malignant tumors. Among them, there is great interest in engineered γδ T cells for ACT. With both adaptive and innate immune characteristics, γδ T cells can be activated by γδ TCRs to recogni...
Autores principales: | Dong, Ruoyu, Zhang, Yixi, Xiao, Haowen, Zeng, Xun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120431/ https://www.ncbi.nlm.nih.gov/pubmed/35603176 http://dx.doi.org/10.3389/fimmu.2022.889051 |
Ejemplares similares
-
γδ T Cells Participating in Nervous Systems: A Story of Jekyll and Hyde
por: Li, Yunxuan, et al.
Publicado: (2021) -
Skin γδ T Cells and Their Function in Wound Healing
por: Hu, Wengang, et al.
Publicado: (2022) -
Paving the Way Towards Universal Chimeric Antigen Receptor Therapy in Cancer Treatment: Current Landscape and Progress
por: Zhang, Yixi, et al.
Publicado: (2020) -
Spleen tyrosine kinase mediates the γδTCR signaling required for γδT cell commitment and γδT17 differentiation
por: Muro, Ryunosuke, et al.
Publicado: (2023) -
GMP-Grade Manufacturing of T Cells Engineered to Express a Defined γδTCR
por: Straetemans, Trudy, et al.
Publicado: (2018)